BRIGHT MINDS BIOSCIENCES INC. (DRUG) — research page
US · us-cm-kg/NASDAQ/DRUG · as of 2026-11-08
Identity and listing
The issuer is BRIGHT MINDS BIOSCIENCES INC., listed on NASDAQ under the ticker DRUG, with ISIN US10919W4050. The record does not hold an LEI for the issuer. Its security type is Non-operating entity type (other), its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is British Columbia, Canada. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | BRIGHT MINDS BIOSCIENCES INC. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | DRUG | source · 2026-11-08 |
| ISIN | US10919W4050 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Non-operating entity type (other) | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | British Columbia, Canada | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 41 filings in the twelve months to 2026-11-08, across 28 filing days. Of these, 19 are regulatory filings, 19 are results, 2 are prospectuses and 1 is a directors' dealings filing. The median gap between filing days is 4 days. The latest filing is dated 2026-11-02, is of type results, and is 6 days before the record date. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days across 4359 issuers. The sector median is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days across 526 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 41 | 4 | 6 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-02 | results | 6-K | 6-K |
| 2026-10-02 | results | 6-K | 6-K — FORM 6-K |
| 2026-10-01 | results | 6-K | 6-K — FORM 6-K |
| 2026-08-17 | results | 6-K | 6-K — FORM 6-K |
| 2026-08-14 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, because the latest annual report cover carries no auditor name tag, and foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations page.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001827401.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/DRUG (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://mcp.us-cm-kg.ai/record/NASDAQ/DRUG (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US10919W4050"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:4b25aa5ed25fe3e8.